APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-helminthic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-helminthic Drugs Market Outlook and Growth Opportunities 2026

Report ID 173964890427 December 2025208 pages

Choose your research edition.

Industry ResearchAnti-helminthic Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-helminthic Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Anti-helminthic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-helminthic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-helminthic Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Anti-helminthic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-helminthic Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-helminthic Drugs market include Anhui Shengying Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. and Jiaozuo Furuitang Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-helminthic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-helminthic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-helminthic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-helminthic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-helminthic Drugs Segment by Company

Anhui Shengying Pharmaceutical Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Chengdu Hengda Pharmaceutical Co., Ltd.

Diao Group Chengdu Pharmaceutical Co., Ltd.

Fujian Dongrui Pharmaceutical Co., Ltd.

Guilin Nanyao Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Jiaozuo Furuitang Pharmaceutical Co., Ltd.

Nanjing Pharmaceutical Factory Co., Ltd.

Shaanxi Hanwang Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Shanghai Tengrui Pharmaceutical Co., Ltd.

Shaoxing Minsheng Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

Anti-helminthic Drugs Segment by Type

Pyrantel Pamoate

Piperazine

Mimbendazole

Praziquantel

Albendazole

Anti-helminthic Drugs Segment by Application

For Veterinary Use

For Human Use

Anti-helminthic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anti-helminthic Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anti-helminthic Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-helminthic Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-helminthic Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-helminthic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-helminthic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-helminthic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-helminthic Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-helminthic Drugs industry.

Chapter 3: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anti-helminthic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anti-helminthic Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-helminthic Drugs Industry Trends Table 2. Anti-helminthic Drugs Industry Drivers Table 3. Anti-helminthic Drugs Industry Opportunities and Challenges Table 4. Anti-helminthic Drugs Industry Restraints Table 5. Global Anti-helminthic Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-helminthic Drugs Revenue Share by Company (2021-2026) Table 7. Global Anti-helminthic Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Anti-helminthic Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Anti-helminthic Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anti-helminthic Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anti-helminthic Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Anti-helminthic Drugs Company, Product Type & Application Table 13. Global Anti-helminthic Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-helminthic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pyrantel Pamoate Table 18. Significant Companies of Piperazine Table 19. Significant Companies of Mimbendazole Table 20. Significant Companies of Praziquantel Table 21. Significant Companies of Albendazole Table 22. Global Anti-helminthic Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Anti-helminthic Drugs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Anti-helminthic Drugs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Anti-helminthic Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Anti-helminthic Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Anti-helminthic Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Anti-helminthic Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Anti-helminthic Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Anti-helminthic Drugs Sales Value Share by Type (2021-2026) Table 31. Global Anti-helminthic Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of For Veterinary Use Table 33. Significant Companies of For Human Use Table 34. Global Anti-helminthic Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Anti-helminthic Drugs Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Anti-helminthic Drugs Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Anti-helminthic Drugs Sales Volume Share by Application (2021-2026) Table 38. Global Anti-helminthic Drugs Sales Volume Share by Application (2027-2032) Table 39. Global Anti-helminthic Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Anti-helminthic Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Anti-helminthic Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Anti-helminthic Drugs Sales Value Share by Application (2021-2026) Table 43. Global Anti-helminthic Drugs Sales Value Share by Application (2027-2032) Table 44. Global Anti-helminthic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Anti-helminthic Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Anti-helminthic Drugs Sales Market Share by Region (2021-2026) Table 47. Global Anti-helminthic Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Anti-helminthic Drugs Sales Market Share by Region (2027-2032) Table 49. Global Anti-helminthic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Anti-helminthic Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Anti-helminthic Drugs Sales Value Share by Region (2021-2026) Table 52. Global Anti-helminthic Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Anti-helminthic Drugs Sales Value Share by Region (2027-2032) Table 54. Global Anti-helminthic Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Anti-helminthic Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Anti-helminthic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Anti-helminthic Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 59. Global Anti-helminthic Drugs Sales Market Share by Country (2021-2026) Table 60. Global Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Anti-helminthic Drugs Sales Market Share by Country (2027-2032) Table 62. Global Anti-helminthic Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Anti-helminthic Drugs Sales Value Market Share by Country (2021-2026) Table 64. Global Anti-helminthic Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Anti-helminthic Drugs Sales Value Market Share by Country (2027-2032) Table 66. Anhui Shengying Pharmaceutical Co., Ltd. Company Information Table 67. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview Table 68. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 70. Anhui Shengying Pharmaceutical Co., Ltd. Recent Development Table 71. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 72. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 73. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 75. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 76. Chengdu Hengda Pharmaceutical Co., Ltd. Company Information Table 77. Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview Table 78. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 80. Chengdu Hengda Pharmaceutical Co., Ltd. Recent Development Table 81. Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information Table 82. Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview Table 83. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 85. Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Development Table 86. Fujian Dongrui Pharmaceutical Co., Ltd. Company Information Table 87. Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview Table 88. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 90. Fujian Dongrui Pharmaceutical Co., Ltd. Recent Development Table 91. Guilin Nanyao Pharmaceutical Co., Ltd. Company Information Table 92. Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview Table 93. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 95. Guilin Nanyao Pharmaceutical Co., Ltd. Recent Development Table 96. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information Table 97. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview Table 98. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 100. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Development Table 101. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information Table 102. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview Table 103. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 105. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Development Table 106. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information Table 107. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview Table 108. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 110. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Development Table 111. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 112. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 113. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 115. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development Table 116. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information Table 117. Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview Table 118. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 120. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Development Table 121. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 122. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 123. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 125. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development Table 126. Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information Table 127. Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview Table 128. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 130. Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Development Table 131. Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information Table 132. Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview Table 133. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 135. Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Development Table 136. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 137. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 138. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 140. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Development Table 141. Southwest Pharmaceutical Co., Ltd. Company Information Table 142. Southwest Pharmaceutical Co., Ltd. Business Overview Table 143. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 145. Southwest Pharmaceutical Co., Ltd. Recent Development Table 146. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information Table 147. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview Table 148. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 150. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Development Table 151. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 152. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 153. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 155. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Anti-helminthic Drugs Distributors List Table 159. Anti-helminthic Drugs Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Anti-helminthic Drugs Product Image Figure 2. Global Anti-helminthic Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-helminthic Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anti-helminthic Drugs Sales (2021-2032) & (K Units) Figure 5. Global Anti-helminthic Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anti-helminthic Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pyrantel Pamoate Image Figure 10. Piperazine Image Figure 11. Mimbendazole Image Figure 12. Praziquantel Image Figure 13. Albendazole Image Figure 14. Global Anti-helminthic Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Anti-helminthic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Anti-helminthic Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Anti-helminthic Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Anti-helminthic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Anti-helminthic Drugs Sales Value Share by Type (2021-2032) Figure 20. For Veterinary Use Image Figure 21. For Human Use Image Figure 22. Global Anti-helminthic Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Anti-helminthic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Anti-helminthic Drugs Sales Volume Share by Application (2021-2032) Figure 25. Global Anti-helminthic Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Anti-helminthic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Anti-helminthic Drugs Sales Value Share by Application (2021-2032) Figure 28. Global Anti-helminthic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Anti-helminthic Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Anti-helminthic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Anti-helminthic Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Anti-helminthic Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. North America Anti-helminthic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Anti-helminthic Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Anti-helminthic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Anti-helminthic Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Anti-helminthic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Anti-helminthic Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. South America Anti-helminthic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Anti-helminthic Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Anti-helminthic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Anti-helminthic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Anti-helminthic Drugs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Anti-helminthic Drugs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Pyrantel Pamoate
  • Piperazine
  • Mimbendazole
  • Praziquantel
  • Albendazole
Applications
  • For Veterinary Use
  • For Human Use
Companies covered
  • Anhui Shengying Pharmaceutical Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Chengdu Hengda Pharmaceutical Co., Ltd.
  • Diao Group Chengdu Pharmaceutical Co., Ltd.
  • Fujian Dongrui Pharmaceutical Co., Ltd.
  • Guilin Nanyao Pharmaceutical Co., Ltd.
  • Hubei Ruihua Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Shaanxi Hanwang Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Shanghai Tengrui Pharmaceutical Co., Ltd.
  • Shaoxing Minsheng Pharmaceutical Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Zhejiang Anbet Pharmaceutical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-helminthic Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Anti-helminthic Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Anti-helminthic Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anti-helminthic Drugs Market Dynamics
  1. 2.1 Anti-helminthic Drugs Industry Trends
  2. 2.2 Anti-helminthic Drugs Industry Drivers
  3. 2.3 Anti-helminthic Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-helminthic Drugs Industry Restraints
3 Anti-helminthic Drugs Market by Company
  1. 3.1 Global Anti-helminthic Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Anti-helminthic Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Anti-helminthic Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Anti-helminthic Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Anti-helminthic Drugs Company Ranking (2024-2026)
  6. 3.6 Global Anti-helminthic Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Anti-helminthic Drugs Company Product Type and Application
  8. 3.8 Global Anti-helminthic Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anti-helminthic Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anti-helminthic Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anti-helminthic Drugs Market by Type
  1. 4.1 Anti-helminthic Drugs Type Introduction
  2. 4.1.1 Pyrantel Pamoate
  3. 4.1.2 Piperazine
  4. 4.1.3 Mimbendazole
  5. 4.1.4 Praziquantel
  6. 4.1.5 Albendazole
  7. 4.2 Global Anti-helminthic Drugs Sales Volume by Type
  8. 4.2.1 Global Anti-helminthic Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Anti-helminthic Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Anti-helminthic Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Anti-helminthic Drugs Sales Value by Type
  12. 4.3.1 Global Anti-helminthic Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Anti-helminthic Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Anti-helminthic Drugs Sales Value Share by Type (2021-2032)
5 Anti-helminthic Drugs Market by Application
  1. 5.1 Anti-helminthic Drugs Application Introduction
  2. 5.1.1 For Veterinary Use
  3. 5.1.2 For Human Use
  4. 5.2 Global Anti-helminthic Drugs Sales Volume by Application
  5. 5.2.1 Global Anti-helminthic Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anti-helminthic Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Anti-helminthic Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Anti-helminthic Drugs Sales Value by Application
  9. 5.3.1 Global Anti-helminthic Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Anti-helminthic Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Anti-helminthic Drugs Sales Value Share by Application (2021-2032)
6 Anti-helminthic Drugs Regional Sales and Value Analysis
  1. 6.1 Global Anti-helminthic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-helminthic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-helminthic Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Anti-helminthic Drugs Sales by Region (2027-2032)
  5. 6.3 Global Anti-helminthic Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anti-helminthic Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anti-helminthic Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anti-helminthic Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Anti-helminthic Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anti-helminthic Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Anti-helminthic Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anti-helminthic Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Anti-helminthic Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anti-helminthic Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anti-helminthic Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anti-helminthic Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Anti-helminthic Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anti-helminthic Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anti-helminthic Drugs Sales Value Share by Country, 2025 VS 2032
7 Anti-helminthic Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Anti-helminthic Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-helminthic Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anti-helminthic Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Anti-helminthic Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Anti-helminthic Drugs Sales by Country (2027-2032)
  6. 7.4 Global Anti-helminthic Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anti-helminthic Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anti-helminthic Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anti-helminthic Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anti-helminthic Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anti-helminthic Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Anhui Shengying Pharmaceutical Co., Ltd.
  2. 8.1.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  6. 8.1.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Beijing Taiyang Pharmaceutical Co., Ltd.
  8. 8.2.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  12. 8.2.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Chengdu Hengda Pharmaceutical Co., Ltd.
  14. 8.3.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  18. 8.3.5 Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Diao Group Chengdu Pharmaceutical Co., Ltd.
  20. 8.4.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  24. 8.4.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Fujian Dongrui Pharmaceutical Co., Ltd.
  26. 8.5.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  30. 8.5.5 Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Guilin Nanyao Pharmaceutical Co., Ltd.
  32. 8.6.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  36. 8.6.5 Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Hubei Ruihua Pharmaceutical Co., Ltd.
  38. 8.7.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  42. 8.7.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  44. 8.8.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  48. 8.8.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  50. 8.9.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  54. 8.9.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Nanjing Pharmaceutical Factory Co., Ltd.
  56. 8.10.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  57. 8.10.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  58. 8.10.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio
  60. 8.10.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 8.11 Shaanxi Hanwang Pharmaceutical Co., Ltd.
  62. 8.11.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  66. 8.11.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  68. 8.12.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  72. 8.12.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
  74. 8.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  78. 8.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Shaoxing Minsheng Pharmaceutical Co., Ltd.
  80. 8.14.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  84. 8.14.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Sichuan Tiande Pharmaceutical Co., Ltd.
  86. 8.15.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  90. 8.15.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Southwest Pharmaceutical Co., Ltd.
  92. 8.16.1 Southwest Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  96. 8.16.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Zhejiang Anbet Pharmaceutical Co., Ltd.
  98. 8.17.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  102. 8.17.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Zhejiang Hisun Pharmaceutical Co., Ltd.
  104. 8.18.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  108. 8.18.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-helminthic Drugs Value Chain Analysis
  2. 9.1.1 Anti-helminthic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-helminthic Drugs Sales Mode & Process
  6. 9.2 Anti-helminthic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-helminthic Drugs Distributors
  9. 9.2.3 Anti-helminthic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst